-
Lundquist Investigator Eiji Yoshihara, Ph.D., Receives Grant to Explore Potential New Pathway for Diabetes Treatment
Beatson Foundation award may help develop a novel technology to generate an infinite supply of insulin producing cells
Research -
International Multi-institutional Collab Unveils Molecular Basis of Pancreatitis
ERRγ deletion causes rapid and progressive pancreatic atrophy H&E staining (upper panel) and Masson’s trichrome staining (middle panel) of pancreas from control (CON) and ERRγ conditional…
Research -
Participants Needed for Healthy Controls Study
We are doing this study to find out why kids with MPS have problems with their bones, joints, brains, and other parts of their body so…
Community, Research -
Lundquist Institute Investigator Dr. Frans Walther Receives Grant to Develop an Aerosolized Lung Surfactant
The non-invasive delivery device will be for use in respiratory distress syndrome (RDS), a significant cause of neonatal mortality and morbidity
Research -
Lundquist Institute Investigator Eiji Yoshihara, PhD., Receives Internationally Prestigious Award for Research on Type 1 Diabetes
JDRF Career Development Awards are highly competitive and given to only a few promising junior researchers each year
Research -
Lundquist Institute Investigator Aims to Improve Stroke Recovery with New Granular Biomaterials
Research is funded by five-year, $2.29 million grant from the National Institute of Neurological Disorders and Stroke.
Research -
Eli Ipp, MD, is Lead Author on a JAMA Open Network Study that Positively Evaluates EyeArt AI System to Prevent Diabetic Vision Loss
The study examines performance of the EyeArt AI system for detecting eyes with more than mild diabetic retinopathy (mtmDR) and vision-threatening diabetic retinopathy (vtDR).
Research -
Institute Investigators Develop a Significant Novel Mouse Model of the Neuropediatric Disorder Ataxia Telangiectasia (A-T)
Ataxia Telangiectasia (A-T) Is a Devastating Disorder in Children Characterized by a Severe Loss of Motor Coordination (Ataxia), Increased Cancer Susceptibility, Immunodeficiency, and Premature Death
Research -
The Lundquist Institute Receives $3 Million From NIH to Expand Male Contraceptive Study
The Lundquist Institute’s Male Contraceptive Efficacy Trial has received an additional $3 million from the National Institutes of Health (NIH) to expand its work and recruit…
Research -
The Lundquist Institute Receives Prestigious CIRM Scholar Research Training Award
The CIRM Grant Will Support Stem Cell Training and Research for the Institute’s PhD Students, Postdoctoral Fellows and Clinical Fellows
Education, Research